Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPre’s Omega-3 Phospholipid Composition Jun 24, 2019
Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100% Patient Randomization Target in Patients with Severe Hypertriglyceridemia Jun 4, 2019
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference May 21, 2019
Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel May 15, 2019
